Valuation dashboard for Solventum Corporation (SOLV) with P/E 10.73, P/B 3.18, EV/EBITDA 7.74 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments.
Analysis Summary
Solventum Corporation reported revenue of $8.32B in the most recent fiscal year, growing at a 5-year CAGR of 2.7%. Net income reached $1.56B, with a 6.5% 5-year CAGR.
Trailing-twelve-month margins: gross margin 54.7%, operating margin 25.0%, net margin 17.3%.
At the current price of $88.03, SOLV trades at a P/E of 10.73 and an ROE of 28.96%. Market capitalisation stands at $15.2B, placing it among large-cap names.
Balance sheet quality for SOLV: current ratio of 1.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 10.73 |
| Price / Book | 3.18 |
| EV / EBITDA | 7.74 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $129.70 |
| vs Current Price | +47.3% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SOLV | Solventum Corporation | $15.2B | 10.73 | 3.18 | 29.0% |
| ALGN | Align Technology, Inc. | $10.3B | 24.95 | 2.80 | 10.1% |
| ENSG | The Ensign Group, Inc. | $10.0B | 26.92 | 4.08 | 16.5% |
| ICLR | ICON Public Limited Company | $12.4B | 37.77 | 1.33 | 2.5% |
| ELAN | Elanco Animal Health Incorporated | $11.2B | 1.68 | -3.0% | |
| RDY | Dr. Reddy's Laboratories Limited | $10.2B | 30.37 | 2.62 | 12.2% |
| EHC | Encompass Health Corporation | $11.9B | 19.26 | 4.56 | 25.0% |
| QGEN | Qiagen N.V. | $9.2B | 22.95 | 2.75 | 11.6% |
Price
| Price | $88.03 |
| Market Cap | $15.2B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | 28.96% |
| Return on Invested Capital | 15.85% |
| Return on Assets | 10.07% |
| Gross Margin | 54.69% |
| Operating Margin | 24.99% |
| Net Margin | 17.26% |
Related companies: ALGN · DOCS · EHC · ELAN · ENSG · ICLR · QGEN
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of SOLV: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks